Filing Details
- Accession Number:
- 0001144204-11-027017
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-09 11:05:02
- Reporting Period:
- 2011-05-09
- Filing Date:
- 2011-05-09
- Accepted Time:
- 2011-05-09 11:05:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1077183 | Neogenomics Inc | NGNM.OB | Services-Testing Laboratories (8734) | 742897368 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1518733 | M Douglas Oort Van | C/O Neogenomics, Inc. 12701 Commonwealth Drive Suite 9 Fort Myers FL US 33913 | Chairman And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-05-06 | 5,000 | $1.45 | 787,290 | No | 4 | P | Indirect | Trust by Self |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | Trust by Self |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 8,600 | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock option (Right to Buy) | $0.80 | 2009-12-31 | 2016-03-15 | 0 | 1,000,000 | Direct |
| Common Stock | Warrant (Right to Buy) | $1.05 | 2009-03-16 | 2014-03-15 | 0 | 625,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2016-03-15 | 0 | 1,000,000 | Direct |
| 2014-03-15 | 0 | 625,000 | Direct |
Footnotes
- On March 15, 2009 Mr. VanOort was granted options to purchase 1,000,000 shares. The grant was comprised of 500,000 time based options and 500,000 performance based options. The first date of vesting when an option became exercisable was December 31, 2009 when 200,000 performance based options vested. Mr. VanOort will have 374,000 time based options vested and exercisable within 60 days of this filing. There are 300,000 performance based options which are not vested or exercisable.
- On March 16, 2009 Mr. VanOort was granted a warrant to purchase 625,000 shares. Of this total 125,000 warrants were immediately exercisable and vested. The remaining 500,000 warrants vest based on performance of the Company stock price and are not exercisable or vested at the present time.
Billionaire Hedge Funds
